Document gDoqqedNBx12jNBog3DQ5nmON

To: From: Cc: Bcc: Received Date: Subject: Cagen, Stuart Z SCC-HSE <stuart.cagen@shell.com> Owen, David DE SC-CHSE-DO <lO=SHELLlOU=OPC/CN=RECIPI ENTS/CN=SNDOW4> 2004-03-2614:42:59 GMT RE: Issue summary example Thanks, I would like to go through next week so that at least the 8D topic is covered. D -----Original Message----- From: Cagen, Stuart Z SCC-HSE Sent: 25 March 2004 00:04 To: Hulse, Michael SCC-CHSEMH Subject: RE: Issue summary example Mike: As requested, here are draft documents for BD and Shanghai. Note I have not collaborated with Patsy on the Shanghai document, and this would need her concurrence. File: Butadiene and the CM.rtf (Compressed)>> File: Shanghai benzene. rtf (Compressed) Stuart Cagen Shell Chem ical LP One Shell Plaza, 910 Louisiana, Houston, TX 77002-4916 Tel: +1 713241 1407 Fax: +1 713241 3325 Other Tel: +1 8326463987 Email: stuart.cagen@shell.com Internet: http://www.shell.com/chemicals -----Original Message----- From: Hulse, Michael SCC-CHSEMH Sent: Wednesday, March 24, 2004 1:48 PM To: Cagen, Stuart Z SCC-HSE Subject: Issue summary example Importance: High File: Biomonitoring of Chemicals.doc (Compressed) Regulatory Issues. doc (Compressed) File: Global Michael Hulse Product Regulatory Advisor Shell Chem ical LP One Shell Plaza, 910 Louisiana, Houston, TX 77002-4916 Tel: +1 713241 0032 Fax: 3325 Email: SH ELL-MCCLU RG-064248 Internet: http://www.shell.com/chemicals SH ELL-MCCLU RG-064249